Ergothioneine and Metal Ions: Why Copper or Iron Chelation Does Not Automatically Mean Incompatibility

Quick Answer

Some Ergothioneine supplier pages warn formulators to keep the ingredient away from metal ions such as copper. Academic literature, however, describes metal chelation as part of Ergothioneine's antioxidant behavior. Those statements are not necessarily contradictory. A molecule can bind a metal ion and reduce metal-catalyzed oxidative damage in one experimental system while still changing color, speciation, activity or stability in a finished cosmetic formulation.

The correct technical question is therefore not Does Ergothioneine bind copper? The answer is yes. The useful question is: what metal species is present, what ligand already holds it, what are the concentrations and pH, and does adding Ergothioneine materially change the finished product?

Recent work makes the chemistry especially clear. A 2026 Antioxidants paper found that Ergothioneine forms Cu(II) complexes, participates in reduction of Cu(II) to Cu(I), and then binds Cu(I) in stable complexes that limit reaction with molecular oxygen.[1] Earlier work showed strong protection against copper-driven oxidative damage to DNA and protein through formation of a redox-inactive Ergothioneine-copper complex.[2]

That evidence supports metal binding as a real chemical interaction. It does not support a universal cosmetic compatibility rule.

For formulation and sourcing, use the sequence:

identify the metal-containing ingredient → define its chemical form and ligand system → define Ergothioneine grade and concentration → map likely interaction → bench-test appearance/pH/rheology → quantify critical actives if needed → run stability → approve only the exact system tested.

Ergothioneine Genuinely Forms Metal Complexes

The interaction is not merely a supplier-theory issue. Classical coordination studies showed that Ergothioneine interacts with divalent metal ions and that the relative complex-formation tendency is particularly strong for copper. In one 1974 study, the reported order among the tested divalent ions placed Cu(II) above Hg(II), Zn(II), Cd(II), Co(II) and Ni(II).[3] A 1976 study then examined copper more directly. Equimolar Cu(II) and Ergothioneine formed a green Cu(II) complex, while excess Ergothioneine produced a yellow Cu(I) complex; spectroscopy and NMR supported sulfur coordination.[4]

The modern 2026 mechanistic study extends this older work. It reported formation of Cu(II)-Ergothioneine complexes, reduction of Cu(II) and stable binding of the resulting Cu(I), using optical spectroscopy, NMR and LC-MS.[1] These are chemically meaningful interactions. A formulation containing freely available copper ions should not be assumed to behave as though Ergothioneine were absent.

Why Chelation Can Be Protective Rather Than Destructive

Transition metals can catalyze oxidative reactions when they cycle between oxidation states in the presence of suitable reactants. Ergothioneine can interrupt some of that chemistry by binding metals and changing their redox behavior. In a 2011 Chemical Research in Toxicology study, 0.1-1.0 mM Ergothioneine strongly protected DNA and protein against oxidation in copper-containing experimental systems. The authors concluded that a redox-inactive Ergothioneine-copper complex was responsible for much of the protection.[2]

Skin-focused reviews also discuss metal chelation as one proposed component of Ergothioneine's antioxidant behavior, particularly in relation to copper- and iron-mediated oxidative chemistry.[5] This is the reason a simple rule such as metal binding = incompatibility is wrong. Chelation can reduce the reactivity of a metal in one system. But a cosmetic formula is not a biochemical test tube, and protection against oxidative damage is not the same thing as preserving the intended function of every metal-containing cosmetic active.

The Key Distinction: Free Metal Ions vs Metal Complexes

A formula may contain metal in very different chemical states. Trace iron or copper contamination from raw materials, process water or equipment is not the same as a deliberately added copper complex. Likewise, a copper salt is not the same as a peptide-chelated copper ingredient. If copper is already coordinated by another ligand, adding a second ligand can create competition, exchange, mixed complexes or no meaningful change under the conditions used. The outcome depends on binding affinity, stoichiometry, pH, solvent environment, concentration, temperature and kinetics.

That means the statement Ergothioneine chelates copper is insufficient to predict whether a finished product will lose activity, change color or remain unchanged. For a named copper-containing active such as a copper peptide, direct compatibility data for the exact peptide, exact Ergothioneine concentration and exact formula are preferable to mechanistic extrapolation. If those data do not exist, the correct status is not compatible or incompatible. It is: requires formulation validation.

Why Color Change Can Be a Useful Warning Signal — But Not a Complete Test

Older copper-complex studies observed visible color differences between Cu(II)- and Cu(I)-Ergothioneine systems.[4] That makes visual monitoring relevant in bench work. If a previously blue, green or colorless metal-containing prototype shifts color after Ergothioneine addition, the change can indicate altered coordination or redox chemistry. But the reverse is not safe logic.

No visible color change does not prove that the active metal complex is unchanged, and a color change does not automatically prove that the formula has failed. The appropriate follow-up depends on what the product needs to preserve: metal oxidation state, peptide integrity, Ergothioneine content, antioxidant performance, sensory profile or another defined critical quality attribute.

Copper Is Not the Only Metal Question

Ergothioneine has also been reported to interact with zinc, cobalt, nickel and other metal ions, and reviews commonly discuss iron binding as relevant to antioxidant function.[3][5] The practical formulation implications will not be identical for every metal. Iron and copper are especially important because of their roles in redox chemistry. Zinc, by contrast, is not redox-active in the same way but can still participate in ligand-exchange and coordination equilibria. Do not copy a copper result onto iron, zinc or magnesium without evidence.

Likewise, do not treat the presence of a metal-element name on an INCI or specification as proof that free metal ion is available to react. The chemical species matters.

A Compatibility Decision Needs More Than an INCI List

The INCI list can identify that metal-containing materials are present, but it does not show their speciation or binding environment.

For a real compatibility review, collect:

• exact Ergothioneine grade, assay and formula inclusion level
• exact metal-containing ingredient and supplier grade
• metal identity and oxidation state where relevant
• whether the metal is free, salt-bound, peptide-bound, amino-acid-bound or otherwise complexed
• total metal concentration and, if available, free or labile metal information
• formula pH and buffer system
• other chelators already present, such as EDTA-type materials, phytate, citrate, amino acids or peptides
• other redox-active ingredients, including ascorbate systems and botanical polyphenols
• process order, hold time and temperature
• packaging materials and potential metal-contact surfaces
• critical finished-product attributes that would indicate a meaningful interaction

Do Not Assume EDTA and Ergothioneine Are Interchangeable Chelators

A formulation chelator is often selected to bind trace metals broadly and improve system stability. Ergothioneine should not automatically be treated as a drop-in replacement for EDTA, phytate or another conventional sequestrant. Its binding behavior is metal-dependent, and in the case of copper it also participates in redox chemistry rather than acting as a purely passive capture agent.[1][3] If a formula requires a validated chelation strategy for oxidation control, preservative robustness or trace-metal management, use a chelator system designed and tested for that purpose.

Ergothioneine may contribute useful chemistry, but the article evidence does not justify replacing established formulation chelators solely because Ergothioneine can bind metals.

Copper Peptides Need a Stricter Compatibility Standard

Copper peptides are a useful example because the copper is not present merely as an unwanted trace contaminant. The metal-ligand complex is part of the identity and intended function of the ingredient. That changes the decision standard. Evidence that Ergothioneine can bind copper and reduce copper-driven oxidative chemistry does not establish that it will preserve the original coordination state of a specific copper peptide. Conversely, a supplier warning about metal binding does not prove that every copper peptide will immediately dissociate.

For a copper-peptide formula, the critical question is whether Ergothioneine changes the metal complex enough to affect the ingredient's defined quality attributes or finished-product performance. A useful study design therefore includes at least four conditions: base formula; base + Ergothioneine; base + copper peptide; and base + both materials. Keep pH, order of addition, temperature and packaging constant.

Compare color and physical stability, but add chemical analysis if the commercial claim depends on retained peptide or copper-complex integrity. Depending on the ingredient and available laboratory capability, that may involve peptide assay, chromatographic profiling, metal speciation or another supplier-supported analytical method. Do not infer compatibility from the fact that both ingredients are individually stable in water. Their interaction begins only when they share the same chemical environment.

This same logic applies to other functional metal complexes: when the metal-ligand structure is itself part of the active, ligand competition deserves a higher level of validation than ordinary trace-metal control.

A Practical Bench Test for Ergothioneine + Metal-Containing Actives

1. Build a control. Prepare the formula without Ergothioneine and document initial appearance, pH, viscosity and any relevant analytical result.
2. Add Ergothioneine at the intended level. Use the actual high-purity grade and assay-corrected inclusion level rather than a generic laboratory reagent assumption.
3. Keep the process identical. Control addition order, temperature, mixing and hold time so that the only intended variable is Ergothioneine.
4. Watch immediate signals. Record color, haze, precipitation, odor, pH and rheology. Photograph color-sensitive systems under consistent lighting.
5. Challenge the interaction. Where useful, compare the metal-containing system with and without the metal active, and the Ergothioneine system with and without the metal active. This separates general formula instability from the specific interaction.
6. Measure the critical species. If the product depends on a copper peptide, metal oxidation state or retained Ergothioneine assay, use a fit-for-purpose analytical method rather than relying only on appearance.
7. Run stability. Include the temperature, light, freeze-thaw or packaging conditions appropriate to the product. Check both physical stability and the chemical attribute that matters to the claim.
8. Approve the exact system. Do not convert one successful prototype into a universal rule for all copper, iron or metal-containing formulas.

The responsible buyer conclusion is therefore conditional: if the intended product contains a functionally important metal complex, do not approve co-formulation from supplier wording or mechanistic theory alone. Validate the exact finished system.

Current Verified Sourcing Option

Compatibility Interpretation Table

How to Read Supplier Compatibility Warnings

A current commercial Ergothioneine ingredient page states that the material can form complexes with metal ions such as Cu2+ and therefore recommends keeping it separate from ingredients containing metal ions. Treat that as supplier-specific formulation guidance, not as a universal scientific prohibition. The warning is useful because it flags a genuine chemical interaction that deserves testing. The academic literature, however, shows that the same interaction can produce stable copper complexes and reduce copper-driven oxidative damage under defined experimental conditions.[1][2]

Before a metal-sensitive project, request the supplier's current TDS, specification, lot COA and any available compatibility or application data for the exact grade. If the supplier only states a generic metal-ion warning, treat that warning as a screening flag and validate the intended finished formula experimentally.

Buyer Decision

Ergothioneine-metal binding is real chemistry, not a marketing phrase. With copper, the interaction can generate stable complexes and reduce metal-driven oxidative damage in defined experimental systems. That does not mean every metal-containing cosmetic is compatible. The correct distinction is between biochemical chelation evidence and finished-formula compatibility. For a formula containing copper, iron or another functionally important metal species, identify the exact metal form and ligand system, then validate the real formulation at the intended Ergothioneine level.

Use appearance as an early signal, not the final answer. When the metal active or Ergothioneine content is critical, add fit-for-purpose chemical measurement and stability testing. That gives the buyer a defensible conclusion for the exact product instead of a universal rule built from one word: chelation.

References

1. Tsentalovich YP, Osik NA, Fomenko MV, Dmitriev NA, Yanshole VV. Mechanism of Cu(II) Detoxification by Ergothioneine: Reduction and Formation of Stable Cu(I) Complexes. Antioxidants. 2026;15(9):1064.
2. Zhu BZ, Mao L, Fan RM, et al. Ergothioneine Prevents Copper-Induced Oxidative Damage to DNA and Protein by Forming a Redox-Inactive Ergothioneine-Copper Complex. Chemical Research in Toxicology. 2011;24(1):30-34.
3. Motohashi N, Mori I, Sugiura Y, Tanaka H. Metal Complexes of Ergothioneine. Chemical and Pharmaceutical Bulletin. 1974;22(3):654-657.
4. Motohashi N, Mori I, Sugiura Y. Complexing of Copper Ion by Ergothioneine. Chemical and Pharmaceutical Bulletin. 1976;24(10):2364-2368.
5. Cheah IK, Halliwell B. Safe and Effective Antioxidant: The Biological Mechanism and Potential Pathways of Ergothioneine in the Skin. Antioxidants. 2023;12(2):314.